Dopapres Tablet

About Dopapres 250 mg Tablet

Dopapres 250 mg Tablet is an antihypertensive medicine containing methyldopa. It works through the brain to lower raised blood pressure by reducing the nerve signals that tighten blood vessels.

There are 7 brands of Methyldopa listed in Bangladesh. The lowest listed price is Aldomet 250 mg Tablet at ৳ 1 per unit.

What is Dopapres 250 mg Tablet?

Dopapres 250 mg Tablet is a centrally acting antihypertensive medicine. Its active ingredient, methyldopa, is converted in the body into a substance that acts on certain receptors in the brain. This reduces the outgoing nerve signals that normally narrow blood vessels, so blood vessels relax and blood pressure falls. It belongs to a group of medicines called central sympatholytics. Doctors prescribe it for hypertension, often when other options are not suitable. The dose and course are decided by the doctor, who will also arrange any monitoring needed. Do not change the dose on your own.

Uses of Dopapres

Dopapres 250 mg Tablet is used to treat hypertension, that is, raised blood pressure. It is a centrally acting antihypertensive medicine, meaning it works through the brain rather than directly on the blood vessels. It may be prescribed alone or alongside other blood pressure medicines. Whether it suits a particular person depends on their overall health and other conditions, so the doctor makes that decision after assessment.

How to use Dopapres

Take Dopapres 250 mg Tablet exactly as your doctor prescribes. The doctor decides the dose, how often to take it and how long the course lasts, and may adjust these over time. Swallow the tablet as advised. Do not stop taking it or change the amount without speaking to your doctor, because blood pressure control needs to be managed carefully. If you miss a dose, ask your doctor or pharmacist what to do rather than guessing.

Side effects of Dopapres

Some people feel drowsy or sedated, especially early in treatment or after a dose increase. Headache, tiredness or weakness can also occur at first. Less common effects include dizziness on standing, swelling or weight gain, a slow heartbeat, nausea, vomiting, constipation or a dry mouth. Unusual effects involving the liver, blood or heart have been reported rarely. Tell your doctor about any side effect that bothers you or does not settle.

Safety and precautions

Dopapres 250 mg Tablet should not be used by people with active liver disease such as acute hepatitis or active cirrhosis, or by anyone whose liver problems were previously linked to methyldopa. It is also not for people allergic to any ingredient, or those taking monoamine oxidase inhibitors. Tell the doctor about previous liver problems, swelling, weight gain or heart problems, and about all other medicines you take. In pregnancy it is classed as category B; methyldopa passes into breast milk, so breastfeeding mothers should ask the doctor first. The doctor decides whether it is suitable for you.

Frequently asked questions

What is Dopapres 250 mg Tablet used for and what kind of medicine is it?

It is used for hypertension, or raised blood pressure. It is a centrally acting antihypertensive medicine containing methyldopa, which works through the brain to reduce nerve signals that narrow blood vessels. Your doctor decides whether it is appropriate for you.

Who should avoid Dopapres 250 mg Tablet or ask the doctor first?

People with active liver disease, or liver problems previously linked to methyldopa, should not take it. It is also unsuitable for anyone allergic to its ingredients or taking monoamine oxidase inhibitors. Tell the doctor about liver problems, swelling or heart problems, and about all other medicines, before starting.

Is Dopapres 250 mg Tablet safe in pregnancy or breastfeeding?

It is classed as pregnancy category B, but methyldopa passes into breast milk. Pregnant or breastfeeding women should speak to the doctor before using it, so the benefits and risks can be weighed for their situation. Do not start or stop it without medical advice.

Can I stop Dopapres 250 mg Tablet on my own?

No. Blood pressure medicine should be stopped or changed only on the doctor's advice. Stopping suddenly or altering the dose can affect blood pressure control. If you have concerns or side effects, speak to your doctor, who will decide the right course of action for you.

Indications

Methyldopa is indicated in Hypertension.

Pharmacology

Methyldopa, or α-methyldopa, is a centrally acting sympatholytic agent and an antihypertensive agent. It is an analog of DOPA (3,4‐hydroxyphenylanine), and it is a prodrug, meaning that the drug requires biotransformation to an active metabolite for therapeutic effects. Methyldopa works by binding to alpha(α)-2 adrenergic receptors as an agonist, leading to the inhibition of adrenergic neuronal outflow and reduction of vasoconstrictor adrenergic signals. Methyldopa exists in two isomers D-α-methyldopa and L-α-methyldopa, which is the active form.

First introduced in 1960 as an antihypertensive agent, methyldopa was considered to be useful in certain patient populations, such as pregnant women and patients with renal insufficiency. Since then, methyldopa was largely replaced by newer, better-tolerated antihypertensive agents; however, it is still used as monotherapy or in combination with hydrochlorothiazide. Methyldopa is also available as intravenous injection, which is used to manage hypertension when oral therapy is unfeasible and to treat hypertensive crisis.

Dosage & Administration

Adults-
  • Initiation of Therapy: The usual starting dosage of Methyldopa is 250 mg two or three times a day in the first 48 hours. The daily dosage then may be increased or decreased, preferably at intervals of not less than two days, until an adequate response is achieved. To minimize the sedation, start dosage increases in the evening. When Methyldopa is given to patients on other antihypertensives, the dose of these agents may need to be adjusted to effect a smooth transition. When Methyldopa is given with antihypertensives other than thiazides, the initial dosage of Methyldopa should be limited to 500 mg daily in divided doses; when Methyldopa is added to a thiazide, the dosage of thiazide need not to be changed.
  • Maintenance Therapy: The usual daily dosage of Methyldopa is 500 mg to 2 g in two to four doses. Although occasional patients have responded to higher doses, the maximum recommended daily dosage is 3 gm. Occasionally tolerance may occur, usually between the second and third month of therapy. Adding a diuretic or increasing the dosage of Methyldopa frequently will restore effective control of blood pressure. A thiazide may be added at any time during Methyldopa therapy and is recommended if therapy'has not been started with a thiazide or if effective control of blood pressure cannot be maintained on 2 gm of Methyldopa daily. Methyldopa is largely excreted by the kidney and patients with impaired renal function may respond to smaller doses. Syncope in older patients may be related to an increased sensitivity and advanced arteriosclerotic vascular disease. This may be avoided by lower doses.
Pediatric Use: Initial dosage is based on 10 mg/kg of body weight daily in two to four doses. The daily dosage then is increased or decreased until an adequate response is achieved. The maximum dosage is 65 mg/kg or 3 gm daily, whichever is less.

Interaction

When Methyldopa is used with other antihypertensive drugs, potentiation of antihypertensive effect may occur. Patients may require reduced doses of anesthetics when on Methyldopa. When Methyldopa and lithium are given concomitantly the patient should be carefully monitored for symptoms of lithium toxicity. Coadministration of Methyldopa with ferrous sulfate or ferrous gluconate is not recommended.

Contraindications

Methyldopa is contraindicated in patients:
  • with active hepatic disease, such as acute hepatitis and active cirrhosis
  • with liver disorders previously associated with Methyldopa therapy
  • with hypersensitivity to any component of these products
  • on therapy with monoamine oxidase (MAO) inhibitors.

Side Effects

Sedation, usually transient, may occur during the initial period of therapy or whenever the dose is increased. Headache, asthenia, or weakness may be noted as early and transient symptoms. The following systemic side effects may rarely occur with the use of Methyldopa- angina pectoris, congestive heart failure, orthostatic hypotension, edema or weight gain, bradycardia, pancreatitis, colitis, vomiting, diarrhea, nausea, constipation, dryness of mouth, hyperprolactinemia, bone marrow depression, leukopenia, granulocytopenia, thrombocytopenia, hemolytic anemia; rheumatoid factor, hepatitis, jaundice, myocarditis, pericarditis, vasculitis, eosinophilia, parkinsonism, bell's palsy, nightmares and reversible mild psychoses or depression, dizziness, lightheadedness, paresthesias, arthralgia, myalgia, nasal stuffiness, rash, amenorrhea, gynecomastia, lactation, impotence. However, significant adverse effects due to Methyldopa have been infrequent and this agent usually is well tolerated.

Pregnancy & Lactation

Pregnancy category B. Methyldopa appears in breast milk. Therefore, caution should be exercised when Methyldopa is given to a nursing woman.

Precautions & Warnings

Methyldopa should be used with caution in patients with a history of previous liver disease or dysfunction. Some patients taking Methyldopa experience clinical edema or weight gain, which may be controlled by use of a diuretic. Methyldopa should not be continued if edema progresses or signs of heart failure appear. Hypertension has recurred occasionally after dialysis in patients given Methyldopa because the drug is removed by this procedure. Rarely involuntary choreoathetotic movements have been observed during therapy with Methyldopa in patients with severe bilateral cerebrovascular disease. If these movements occur, stop therapy

Overdose Effects

Acute overdosage may produce acute hypotension with other responses attributable to brain and gastrointestinal malfunction (excessive sedation, weakness, bradycardia, dizziness, lightheadedness, constipation, distention, flatus, diarrhea, nausea, vomiting). In the event of overdosage, symptomatic and supportive measures should be employed. When ingestion is recent, gastric lavage or emesis may reduce absorption. When ingestion has been earlier, infusions may be helpful to promote urinary excretion.

Storage Conditions

Do not store above 30°C. Keep out of the reach of children.

Alternative brands of Methyldopa

Other brands with the same generic name, cheapest first.

Dopamet Tablet

250 mg

Methyldopa

Opsonin Pharma Limited

৳ 3.92 ৳ 4.00 2% off per unit

Fidopa Tablet

250 mg

Methyldopa

Synovia Pharma PLC.

৳ 3.92 ৳ 4 2% off per unit

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.